Dallas, TX – Aug 27, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new analyst report covering the company’s recent biopharmaceutical cannabis extract business development updates.  The report has been released by Goldman Small Cap Research after market today, August 27,  2019, and can be found on Goldman’s website www.goldmanresearch.com.  The report speculates a potential KALY price per share of $0.05.  “Already generating...